Gut Microbiota, an Additional Hallmark of Human Aging and Neurodegeneration
•Gut-brain axis is involve in aged-related neurological disorders like Alzheimer.•Oral and gut dysbiosis has been associated to biomarkers of cognitive decline.•Microbial-derived metabolites could modulate tau and β-amyloid deposition.•Gut microbiome could affect brain activity via epigenetic change...
Gespeichert in:
Veröffentlicht in: | Neuroscience 2023-05, Vol.518, p.141-161 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Gut-brain axis is involve in aged-related neurological disorders like Alzheimer.•Oral and gut dysbiosis has been associated to biomarkers of cognitive decline.•Microbial-derived metabolites could modulate tau and β-amyloid deposition.•Gut microbiome could affect brain activity via epigenetic changes.•Oral and gut dysbiosis as additional hallmark of human aging and neurodegeneration.
Gut microbiota represents a diverse and dynamic population of microorganisms harbouring the gastrointestinal tract, which influences host health and disease. Bacterial colonization of the gastrointestinal tract begins at birth and changes throughout life, with age being one of the conditioning factors for its vitality. Aging is also a primary risk factor for most neurodegenerative diseases. Among them, Alzheimeŕs disease (AD) is probably the one where its association with a state of dysbiosis of the gut microbiota has been most studied. In particular, intestinal microbial-derived metabolites have been associated with β-amyloid formation and brain amyloid deposition, tau phosphorylation, as well as neuroinflammation in AD patients. Moreover, it has been suggested that some oral bacteria increase the risk of developing AD. However, the causal connections among microbiome, amyloid-tau interaction, and neurodegeneration need to be addressed. This paper summarizes the emerging evidence in the literature regarding the link between the oral and gut microbiome and neurodegeneration with a focus on AD. Taxonomic features of bacteria as well as microbial functional alterations associated with AD biomarkers are the main points reviewed. Data from clinical studies as well as the link between microbiome and clinical determinants of AD are particularly emphasized. Further, relationships between gut microbiota and age-dependent epigenetic changes and other neurological disorders are also described. Together, all this evidence suggests that, in some sense, gut microbiota can be seen as an additional hallmark of human aging and neurodegeneration. |
---|---|
ISSN: | 0306-4522 1873-7544 |
DOI: | 10.1016/j.neuroscience.2023.02.014 |